Safety and tolerability of lapatinib ditosylate given concurrently with docetaxel, carboplatin, and trastuzumab (TCHL) as part of adjuvant therapy for patients with HER2+ breast cancer: Pilot data from the North Central Cancer Treatment Group Trial N083E.
- Citation:
- J Clin Oncol vol 28 (15s) abstr 565
- Meeting Instance:
- ASCO 2010
- Year:
- 2010
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 2113
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- C. Bueno Hume A. Moreno-Aspitia D. Hillman B. Chen A. Perez R. Jenkins A. C. Dueck D. B. Johnson R. Carolla E. Perez
- Networks:
- Study
- NCCTG-N083E
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: